BioVendor Group has recently acquired from SqLab Labor GmbH the remaining minority stake in ViennaLab Diagnostics GmbH. ViennaLab is now a 100% member of the BioVendor Group. BioVendor Group, an international diagnostics holding with headquarters in Brno, Czech Republic, currently…
Progress continues in the development of a rapid platform for diagnosing Malaria using only a saliva sample at Oasis Diagnostics®. Project Leader Rhoel Dinglasan (PhD, MPH, MPhil) describes his hopes surrounding the project along with Congressman Ted Yoho (R-FL) in…
Malaria remains a major global heath burden with as much as a third of the global population at risk of disease. Importantly, it is the leading cause of death for children under five, especially in Sub-Saharan Africa. The malaria elimination…
Friends and colleagues of Oasis Commonwealth Scientific & Industrial Research Organisation, CSIRO, are preparing for a summer time symposium to discussthe latest and greatest in the non-invasive / saliva world. The effort is spearheaded by a triumverate of big names…
CEO Paul Slowey returned from the 2019 International Symposium on Cryobiology and Living Biobanking (CBLB 2019) today following a great event looking at preserving the myriad of clinical samples being tested upon in today’s laboratories. “With the continuous development of…
Dr. Jill Maron, Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center, has recently delivered an excellent Tedx Talk describing her use of salivary diagnostics in her work with the most vulnerable population possible: premature infants. Dr….
The Saliva Technology Application Research Symposium (STARS) is preparing for another successful conference for 2018. STARS, like NASS, is an excellent opportunity for finding the newest and cutting edge research being conducted using saliva as a specimen of choice. For more…
In February of 2021 Viennalabs Diagnostics released their most updated version of the Viennalabs StripAssay® Evaluator software to date, version 2.17.2021.416. This new version includes a host of upgrades to the user interface as well as updating assay definition files….
To all of the users of the StripAssay® Evaluator Software from Viennalabs, an updated version has been released and is now available. The latest update 2.12.2018.212 of StripAssay® Evaluator software is available for free download at: This Link If you should…
CEO Paul Slowey was recently quoted in an article in The Columbian, the leading news and information provider for Vancouver and Clark County, Washington. The article, titled “Clark County strives to capitalize on surging life sciences industry”, discusses the economic climate…
Professor Chamindie Punyadeera from QUT’s Institute of Health and Biomedical Innovation was recently featured in a news article discussing her research into HPV Throat Cancers. You can see the full story at this Link, which also includes an informative video. …
This September in Portland Oregon the Oregon Health and Sciences University will be hosting the North American Saliva Symposium. The Symposium will feature many of our prestigious speakers from the past such as Dr. David Wong (UCLA) and Dr. Jill Maron (Tufts Medical…
Oasis Diagnostics Supports Neonatal Salivary ‘Omic’ Research
Oasis Diagnostics® is proud to have CEO Paul Slowey presenting a lecture on “Advancements in Salivary Diagnostics Through Novel Collection Technologies” at the First Asia-Pacific Saliva Symposium. Dr. Slowey is joined by a cadre of other big names in the field…
Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking Workshop (IgA as a diagnostic tool) in 3rd Annual Conference of Pak Association for Dental Research (IADR Pakistan Section) at Dow Institute of Biotechnology and Biomedical Sciences (DRIBBS)….
Oasis Diagnostics® will be exhibiting at the 2016 MEDICA Tradefair this year in booth D15-5. Oasis’ own CEO Paul Slowey will be joined by Central Region/International Sales Rep Peter van Arkens and together they will be showing off the latest…
Oasis Diagnostics® is proud to sponsor the Present and Future of Salivary Diagnostics: Workshop / Saliva Camp at the Universidade Católica Portuguesa in Viseu, Portugal. The event sees a range of presentations and speakers covering topics such as “Worldwide view of Salivary Research” (Dr,…
Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking and Proteins Analysis for Disease Detection” at CMH Lahore Medical and Institute of Dentistry, Lahore, Pakistan. The event sees a range of presentations and speakers covering topics such…
Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking and Proteins Analysis for Disease Detection” at National Center for Proteomics, Karachi University, Pakistan. The event sees a range of presentations and speakers covering topics such as “Human…
Oasis Diagnostics Corporation now represents the line of immunochromatography, molecular biology, monoclonal antibody, and recombinant antigen products from Operon S.A. Operon is a leading company in technology and “in vitro” diagnostic products, with a solid reputation. The Molecular Biology area in Operon…
In a collaboration between Oasis Diagnostics® Corporation and the UCLA School of Dentistry, a paper has been released covering the effective use of the RNAPro•SAL™ Oral Specimen Collection System. The paper discusses the lack of a suitable collection and extraction system, and…
Vancouver Business Journal – October 03, 2014 Paul Slowey came a long way to start a Vancouver company that sells diagnostic medical equipment all around the world. His Oasis Diagnostics Corporation sells saliva collecting and testing tools that help medical…
[OASIS] is the recipient of a research award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to validate OASIS’ development of a non-invasive, saliva-based, rapid test for Parkinson’s disease detection and diagnosis. OASIS will collaborate with Dr. Charles…
Award of a $1.3 Million Dollar Grant for Saliva Stress Test Development Vancouver, WA (PRWEB) August 13, 2013 — Oasis Diagnostics® Corporation, a leader in the development and commercialization of oral sample collection systems for nucleic acids, proteins and small…
When I was a child I dreamed like many others of becoming an astronaut, and I kept that dream alive as an adult: it is still inside of me, strong and irresistible. So begins the story of Balwant Rai, one of…
Oasis Diagnostics has received a grant from NIH to develop a point of care test that will determine from saliva specimens how stressed an individual is, in 15 minutes or less. Oasis Diagnostics will collaborate with the University of New…
Oasis Diagnostics Corp has licensed technology for the non-invasive diagnosis of Alzheimer’s disease and Parkinson’s disease from Drs. Balwant Rai and Jasdeep Kaur. Using a series of proprietary biomarkers, Oasis will develop a rapid saliva test for these debilitating diseases…
Southwest Washington PubTalk marked its two-year anniversary Thursday evening with progress reports from leaders of six locally connected startups who had been featured speakers in earlier PubTalk sessions. More than 130 people attended the business networking event at the Fort…
Southwest Washington PubTalk marked its two-year anniversary Thursday evening with progress reports from leaders of six locally connected startups who had been featured speakers in earlier PubTalk sessions. More than 130 people attended the business networking event at the Fort…
Oasis Diagnostics Corp. has licensed technology for the non-invasive diagnosis of Alzheimer’s disease and Parkinson’s disease from Drs. Balwant Rai and Jasdeep Kaur. Using a series of proprietary biomarkers, Oasis will develop a rapid saliva test for these debilitating diseases…
Oasis Diagnostics has received a grant from NIH to develop a point of care test that will determine from saliva specimens how stressed an individual is, in 15 minutes or less. Oasis Diagnostics will collaborate with the University of New…
Oasis Diagnostics® Versi•SAL® is features in FOX 11 News video report. Spit Leads to Cancer Detection Breakthrough?: MyFoxLA.com
Amarillo, Texas, January 14, 2011 — Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) and Oasis Diagnostics® Corporation today announced that they have entered into an agreement under which Oasis will exclusively market Maxisal®, ABI’s dietary supplement for enhancement of salivary function,…
Oasis Diagnostics® Corporation has received an investment award from a noted organization devoted to helping visionary entrepreneurs in the Pacific Northwest. Oasis was selected by the Zino Society from among 12 candidates whose commitment to new technology stands out in…
With TechLink assistance, Bamburgh Marrsh (BAMA) of Vancouver, Washington, has licensed a Navy-developed technology for rapid tuberculosis diagnosis using oral fluids (saliva). BAMA was founded in 2002 specifically for the purpose of pioneering new applications using novel saliva-based diagnostic systems….
The latest defense against bioterrorism may use your own saliva. A new toothbrush-sized field test developed by the Navy provides a rapid, inexpensive way to determine protection levels against anthrax. A test strip samples saliva and changes color within minutes…
